Breaking News Instant updates and real-time market news.

APTO

Aptose Biosciences

$5.14 /

-0.075 (-1.44%)

16:24
08/04/20
08/04
16:24
08/04/20
16:24

Aptose Biosciences reports Q2 EPS (21c), consensus (15c)

"COVID-19 did not have a significant impact on our results of operations for the quarter ended June 30, 2020; although the pandemic did necessitate reconfiguration of office space and the introduction of numerous policies and processes to ensure safety of employees and guests. We have not experienced and do not foresee material delays to the enrollment of patients or timelines for the CG-806 Phase 1a/b trial due to the variety of clinical sites that we have actively recruited for this trial. APTO-253 is administered intravenously, which requires the need for hospital / clinical site resources to assist and monitor patients during each infusion and based on the current conditions caused by COVID-19, future enrollment of patients on this trial is likely to be negatively impacted. Monitoring across all ongoing and planned studies will be impacted by COVID-19, necessitating more remote visits versus on-site; risk-based monitoring plans will minimize the impact on deliverables. As of the date of this report, we have not experienced material delays in the manufacturing of CG-806 or APTO-253 related to COVID-19. Should our manufacturers be required to shut down their facilities due to COVID-19 for an extended period of time, our trials may be negatively impacted"

  • 04

    Aug

  • 17

    Dec

  • 16

    Jul

APTO Aptose Biosciences
$5.14 /

-0.075 (-1.44%)

06/12/20 Piper Sandler
Aptose Biosciences' EHA update 'incrementally positive,' says Piper Sandler
06/12/20 JonesTrading
JonesTrading optimistic about potential of Aptose Biosciences' CG-806
02/20/20 Maxim
Aptose Biosciences initiated with a Buy at Maxim
02/20/20 Maxim
Aptose Biosciences initiated with a Buy at Maxim

TODAY'S FREE FLY STORIES

General news
Asian Market Update: » 01:45
10/23/20
10/23
01:45
10/23/20
01:45

Asian Market Update:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
U.S. Markit PMIs preview » 01:45
10/23/20
10/23
01:45
10/23/20
01:45

U.S. Markit PMIs preview:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Syndicate
Milestone Pharmaceuticals 8.571M share Spot Secondary priced at $5.25 » 21:02
10/22/20
10/22
21:02
10/22/20
21:02
MIST

Milestone Pharmaceuticals

$6.99 /

+0.18 (+2.64%)

The deal size was…

The deal size was increased to $45M of common stock from $40M of common stock and the deal priced at the high-end of the $5.00-$5.25 range. Jefferies and Piper Sandler acted as joint book running managers for the offering. 21:00 update

ShowHide Related Items >><<
MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

07/29/20 Oppenheimer
Oppenheimer upgrades Milestone to Outperform on 'best-case' FDA outcome
07/29/20 Oppenheimer
Milestone Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
07/24/20
Fly Intel: Top five analyst upgrades
07/24/20 Jefferies
Jefferies upgrades Milestone to Buy on 'major' FDA win
MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

  • 23
    Oct
  • 20
    Nov
MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
10/22/20
10/22
20:25
10/22/20
20:25
AXP

American Express

$104.80 /

+3.34 (+3.29%)

, ITW

Illinois Tool Works

$201.75 /

-0.94 (-0.46%)

, FHN

First Horizon

$11.45 /

+0.6 (+5.53%)

, BLMN

Bloomin' Brands

$17.72 /

+0.63 (+3.69%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include American Express (AXP), consensus $1.33... Illinois Tool Works (ITW), consensus $1.46... First Horizon National Corp (FHN), consensus 21c... Bloomin' Brands (BLMN), consensus (35c).

ShowHide Related Items >><<
ITW Illinois Tool Works
$201.75 /

-0.94 (-0.46%)

FHN First Horizon
$11.45 /

+0.6 (+5.53%)

BLMN Bloomin' Brands
$17.72 /

+0.63 (+3.69%)

AXP American Express
$104.80 /

+3.34 (+3.29%)

AXP American Express
$104.80 /

+3.34 (+3.29%)

10/09/20
Fly Intel: Top five analyst downgrades
10/09/20 JPMorgan
American Express price target raised to $106 from $97 at JPMorgan
10/09/20 Susquehanna
American Express downgraded to Neutral from Positive at Susquehanna
09/23/20
Fly Intel: Top five analyst downgrades
ITW Illinois Tool Works
$201.75 /

-0.94 (-0.46%)

10/13/20 Deutsche Bank
Illinois Tool Works price target raised to $173 from $168 at Deutsche Bank
10/09/20 Wells Fargo
Illinois Tool Works price target raised to $220 from $205 at Wells Fargo
08/25/20 Barclays
Illinois Tool Works initiated with an Equal Weight at Barclays
08/03/20 Wells Fargo
Illinois Tool Works price target raised to $205 from $180 at Wells Fargo
FHN First Horizon
$11.45 /

+0.6 (+5.53%)

10/08/20 Jefferies
First Horizon upgraded to Buy from Hold at Jefferies
09/22/20 Raymond James
First Horizon upgraded to Strong Buy from Outperform at Raymond James
08/20/20 Goldman Sachs
First Horizon reinstated with a Buy at Goldman Sachs
08/17/20 Morgan Stanley
First Horizon resumed with an Equal Weight at Morgan Stanley
BLMN Bloomin' Brands
$17.72 /

+0.63 (+3.69%)

10/20/20 JPMorgan
Bloomin' Brands price target raised to $20 from $16 at JPMorgan
09/14/20 Raymond James
Bloomin' Brands price target raised to $20 from $18 at Raymond James
09/01/20
Fly Intel: Top five analyst upgrades
09/01/20 Raymond James
Raymond James upgrades casual restaurant laggard Bloomin' Brands to Strong Buy
ITW Illinois Tool Works
$201.75 /

-0.94 (-0.46%)

FHN First Horizon
$11.45 /

+0.6 (+5.53%)

BLMN Bloomin' Brands
$17.72 /

+0.63 (+3.69%)

AXP American Express
$104.80 /

+3.34 (+3.29%)

AXP American Express
$104.80 /

+3.34 (+3.29%)

FHN First Horizon
$11.45 /

+0.6 (+5.53%)

BLMN Bloomin' Brands
$17.72 /

+0.63 (+3.69%)

AXP American Express
$104.80 /

+3.34 (+3.29%)

BLMN Bloomin' Brands
$17.72 /

+0.63 (+3.69%)

AXP American Express
$104.80 /

+3.34 (+3.29%)

Recommendations
Tractor Supply price target raised to $170 from $162 at Baird » 20:13
10/22/20
10/22
20:13
10/22/20
20:13
TSCO

Tractor Supply

$137.02 /

-12.065 (-8.09%)

Baird analyst Peter…

Baird analyst Peter Benedict raised the firm's price target on Tractor Supply to $170 from $162 and keeps an Outperform rating on the shares. The analyst is positive on the plan of the company CEO Hal Lawton to reinvest some of its "unprecedented financial benefits". Benedict says the market increasingly rewarding "durable winners," and he would recommend buying Tractor Supply shares on today's post-earnings pullback.

ShowHide Related Items >><<
TSCO Tractor Supply
$137.02 /

-12.065 (-8.09%)

TSCO Tractor Supply
$137.02 /

-12.065 (-8.09%)

10/22/20 Baird
Tractor Supply results robust as company re-invests forward, says Baird
10/19/20 RBC Capital
Tractor Supply price target raised to $167 from $162 at RBC Capital
10/16/20 Baird
Tractor Supply survey shows demand remains firm, says Baird
10/15/20 Wells Fargo
Tractor Supply price target raised to $170 from $165 at Wells Fargo
TSCO Tractor Supply
$137.02 /

-12.065 (-8.09%)

TSCO Tractor Supply
$137.02 /

-12.065 (-8.09%)

Syndicate
Brickell Biotech 20.83M share Spot Secondary priced at $0.72 » 20:04
10/22/20
10/22
20:04
10/22/20
20:04
BBI

Brickell Biotech

$0.72 /

-0.1078 (-13.02%)

Oppenheimer is acting as…

Oppenheimer is acting as sole book running manager for the offering.

ShowHide Related Items >><<
BBI Brickell Biotech
$0.72 /

-0.1078 (-13.02%)

BBI Brickell Biotech
$0.72 /

-0.1078 (-13.02%)

09/25/20 Lake Street
Approval in Japan validating for Brickell Biotech, says Lake Street
08/28/20 Lake Street
Brickell Biotech initiated with a Buy at Lake Street
08/25/20 Oppenheimer
Brickell Biotech initiated with an Outperform at Oppenheimer
  • 18
    Jun
Hot Stocks
TransAlta Renewables executes 15-year contract extension in Western Australia » 20:01
10/22/20
10/22
20:01
10/22/20
20:01
TRSWF

TransAlta Renewables

$0.00 /

+ (+0.00%)

, BHP

BHP Group

$51.74 /

+0.39 (+0.76%)

TransAlta Renewables…

TransAlta Renewables (TRSWF) "announced that Southern Cross Energy has amended and extended its current power purchase agreement with BHP Billiton Nickel West Pty Ltd (BHP) in respect of SCE's 245 MW of generation facilities in the Goldfields region of Western Australia. The amendment to the PPA replaces the previous contract that was scheduled to expire December 31, 2023. The Company owns an indirect economic interest in SCE. The PPA amendment extends the term to December 31, 2038 and provides SCE with the exclusive right to supply electrical energy to BHP's mining operations located in the Goldfields region of Western Australia. The amendment preserves SCE's current economic benefit to 2023, while also providing SCE a return of and on new capital investments which will be required to support BHP's future power requirements and recently announced emission reduction targets. The PPA provides BHP with the ability to integrate renewable electricity generation, including solar and wind, with energy storage technologies, to meet its emissions reduction targets and deliver lower carbon, sustainable nickel to its customers. The amended PPA also provides BHP participation rights in new capital investments, subject to the satisfaction of certain conditions."

ShowHide Related Items >><<
BHP BHP Group
$51.74 /

+0.39 (+0.76%)

TRSWF TransAlta Renewables
$0.00 /

+ (+0.00%)

10/21/20 National Bank
TransAlta Renewables downgraded to Sector Perform at National Bank
10/16/20 Scotiabank
TransAlta Renewables price target raised to C$17.50 from C$16.50 at Scotiabank
10/15/20 CIBC
TransAlta Renewables downgraded to Neutral from Outperformer at CIBC
10/02/20 Credit Suisse
TransAlta Renewables initiated with a Neutral at Credit Suisse
BHP BHP Group
$51.74 /

+0.39 (+0.76%)

09/30/20 Credit Suisse
BHP Group upgraded to Outperform from Neutral at Credit Suisse
09/30/20 Credit Suisse
BHP Group upgraded to Outperform from Neutral at Credit Suisse
09/16/20 Jefferies
Jefferies upgrades 'go-to' miner BHP to Buy
09/16/20 Jefferies
Rio Tinto removed from US Franchise Picks List at Jefferies
BHP BHP Group
$51.74 /

+0.39 (+0.76%)

BHP BHP Group
$51.74 /

+0.39 (+0.76%)

BHP BHP Group
$51.74 /

+0.39 (+0.76%)

BHP BHP Group
$51.74 /

+0.39 (+0.76%)

Recommendations
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler » 19:36
10/22/20
10/22
19:36
10/22/20
19:36
GILD

Gilead

$60.68 /

+0.44 (+0.73%)

Piper Sandler analyst…

Piper Sandler analyst Tyler Van Buren keeps his Overweight rating and $95 price target on Gilead after the FDA announced that it has granted a full approval for Veklury, or remdesivir, in treatment of COVID-19. The analyst says the decision signals the FDA's confidence in the ACTT-1 study results, while its EUA on pediatric use highlights its comfort regarding the drug's safety. Van Buren adds that he would be "curious to learn more about post-marketing requirements that have been agreed upon", though regardless of the terms, the analyst contends that the drug could generate over $1B in sales for Gilead during the second half of the year assuming the current case rate.

ShowHide Related Items >><<
GILD Gilead
$60.68 /

+0.44 (+0.73%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
09/30/20 Jefferies
Regeneron antibody cocktail results positive for vaccines, says Jefferies
09/24/20 H.C. Wainwright
Durect study designed to support full approval, says H.C. Wainwright
GILD Gilead
$60.68 /

+0.44 (+0.73%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

Earnings
OP Bancorp reports Q3 EPS 23c, two estimates 18c » 19:14
10/22/20
10/22
19:14
10/22/20
19:14
OPBK

OP Bancorp

$6.32 /

-0.08 (-1.25%)

Reports Q3 NII $11.4M vs.…

Reports Q3 NII $11.4M vs. $11.2M last year. Reports Q3 net interest margin 3.66% vs. 4.13% last year. Q3 provision for loan losses was $1.4 million, compared to $2.0 million for the second quarter of 2020 and $290,000 for the third quarter of 2019, in response to changes in qualitative economic and business conditions amid COVID-19 pandemic.

ShowHide Related Items >><<
OPBK OP Bancorp
$6.32 /

-0.08 (-1.25%)

OPBK OP Bancorp
$6.32 /

-0.08 (-1.25%)

Syndicate
Clarus withdraws proposed $85M offering of convertible senior notes due 2026 » 18:52
10/22/20
10/22
18:52
10/22/20
18:52
CLAR

Clarus

$15.20 /

+0.59 (+4.04%)

Clarus announced that, as…

Clarus announced that, as a result of equity capital markets volatility it has decided not to proceed with its previously announced proposed registered offering of convertible senior notes due 2026 in the aggregate amount of $85M. Management determined that, because the proposed transaction was opportunistic in nature and the terms and conditions offered to Clarus did not meet its expectations or recognize the future value expected for Clarus stockholders, it was inadvisable to proceed with the offering at this time.

ShowHide Related Items >><<
CLAR Clarus
$15.20 /

+0.59 (+4.04%)

CLAR Clarus
$15.20 /

+0.59 (+4.04%)

09/18/20 Lake Street
Clarus price target raised to $17 from $15 at Lake Street
09/04/20
Fly Intel: Top five analyst initiations
09/04/20 William Blair
Clarus initiated with an Outperform at William Blair
07/24/20 Roth Capital
Clarus upgraded to Buy from Neutral at Roth Capital
CLAR Clarus
$15.20 /

+0.59 (+4.04%)

CLAR Clarus
$15.20 /

+0.59 (+4.04%)

On The Fly
Fly Intel: After-Hours Movers » 18:50
10/22/20
10/22
18:50
10/22/20
18:50
SCKT

Socket Mobile

$1.42 /

-0.05 (-3.40%)

, SAM

Boston Beer

$918.98 /

+6.49 (+0.71%)

, FFBC

First Financial Bancorp

$14.53 /

+0.68 (+4.91%)

, BOOM

DMC Global

$34.55 /

+1.25 (+3.75%)

, MAT

Mattel

$12.93 /

+0.475 (+3.81%)

, COF

Capital One

$76.98 /

+3.24 (+4.39%)

, SAVA

Cassava Sciences

$8.84 /

-0.07 (-0.79%)

, GILD

Gilead

$60.68 /

+0.44 (+0.73%)

, MIST

Milestone Pharmaceuticals

$6.99 /

+0.18 (+2.64%)

, CYBE

Cyberoptics

$37.71 /

+1.31 (+3.60%)

, LLNW

Limelight Networks

$6.18 /

+0.05 (+0.82%)

, USX

U.S. Xpress Enterprises

$9.34 /

+0.02 (+0.21%)

, EHTH

eHealth

$82.01 /

+0.21 (+0.26%)

, INTC

Intel

$53.98 /

+0.49 (+0.92%)

, MANH

Manhattan Associates

$103.40 /

+4.62 (+4.68%)

, STX

Seagate

$51.80 /

+0.06 (+0.12%)

, VRSN

VeriSign

$207.96 /

+2.22 (+1.08%)

, RHI

Robert Half

$56.48 /

+1.1298 (+2.04%)

Check out this evening's…

ShowHide Related Items >><<
VRSN VeriSign
$207.96 /

+2.22 (+1.08%)

USX U.S. Xpress Enterprises
$9.34 /

+0.02 (+0.21%)

STX Seagate
$51.80 /

+0.06 (+0.12%)

SAVA Cassava Sciences
$8.84 /

-0.07 (-0.79%)

SAM Boston Beer
$918.98 /

+6.49 (+0.71%)

RHI Robert Half
$56.48 /

+1.1298 (+2.04%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MAT Mattel
$12.93 /

+0.475 (+3.81%)

MANH Manhattan Associates
$103.40 /

+4.62 (+4.68%)

LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

EHTH eHealth
$82.01 /

+0.21 (+0.26%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

BOOM DMC Global
$34.55 /

+1.25 (+3.75%)

SCKT Socket Mobile
$1.42 /

-0.05 (-3.40%)

SAM Boston Beer
$918.98 /

+6.49 (+0.71%)

10/15/20 Deutsche Bank
Boston Beer price target raised to $835 from $656 at Deutsche Bank
09/03/20 MKM Partners
Boston Beer price target raised to $780 from $353 at MKM Partners
09/02/20 Citi
Boston Beer price target raised to $1,015 from $815 at Citi
08/27/20 Guggenheim
Boston Beer price target raised to $977 from $822 at Guggenheim
FFBC First Financial Bancorp
$14.53 /

+0.68 (+4.91%)

BOOM DMC Global
$34.55 /

+1.25 (+3.75%)

09/11/20 Sidoti
DMC Global re-initiated with a Neutral at Sidoti
08/20/20 Stifel
DMC Global price target raised to $44 from $33 at Stifel
03/09/20 Roth Capital
DMC Global downgraded to Neutral from Buy at Roth Capital
02/21/20 Roth Capital
DMC Global earnings exceed preannouncement, says Roth Capital
MAT Mattel
$12.93 /

+0.475 (+3.81%)

10/19/20 JPMorgan
Mattel price target raised to $17.50 from $15 at JPMorgan
10/08/20 Jefferies
Set-up for toy companies for Q3 'favorable,' says Jefferies
07/24/20 MKM Partners
Mattel price target raised to $13 from $9 at MKM Partners
06/03/20
Fly Intel: Top five analyst upgrades
COF Capital One
$76.98 /

+3.24 (+4.39%)

10/09/20 JPMorgan
Capital One price target raised to $86.50 from $72 at JPMorgan
07/31/20 Wolfe Research
Capital One initiated with an Outperform at Wolfe Research
07/22/20 Oppenheimer
Capital One price target raised to $69 from $63 at Oppenheimer
07/22/20 Piper Sandler
Capital One price target raised to $82 from $77 at Piper Sandler
SAVA Cassava Sciences
$8.84 /

-0.07 (-0.79%)

10/22/20 Cantor Fitzgerald
Cassava Sciences initiated with an Overweight at Cantor Fitzgerald
09/23/20 H.C. Wainwright
Cassava Sciences upgraded to Buy from Neutral at H.C. Wainwright
09/14/20 Maxim
Cassava upgraded to Buy at Maxim after second analysis of AD drug data
09/14/20 Maxim
Cassava Sciences upgraded to Buy from Hold at Maxim
GILD Gilead
$60.68 /

+0.44 (+0.73%)

10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
09/30/20 Jefferies
Regeneron antibody cocktail results positive for vaccines, says Jefferies
09/24/20 H.C. Wainwright
Durect study designed to support full approval, says H.C. Wainwright
MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

07/29/20 Oppenheimer
Oppenheimer upgrades Milestone to Outperform on 'best-case' FDA outcome
07/29/20 Oppenheimer
Milestone Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
07/24/20
Fly Intel: Top five analyst upgrades
07/24/20 Jefferies
Jefferies upgrades Milestone to Buy on 'major' FDA win
CYBE Cyberoptics
$37.71 /

+1.31 (+3.60%)

06/18/20 Craig-Hallum
Cyberoptics price target raised to $43 from $33 at Craig-Hallum
06/09/20
Cyberoptics downgraded to Neutral from Buy at Dougherty
04/24/20 Lake Street
Cyberoptics investors to be pleased with 'impressive' guidance, says Lake Street
02/20/20 Craig-Hallum
Cyberoptics price target raised to $29 from $20 at Craig-Hallum
LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

10/15/20 DA Davidson
Fastly price target lowered to $105 from $115 at DA Davidson
09/18/20 Truist
Limelight Networks initiated with a Buy at Truist
09/18/20 Truist
Limelight Networks initiated with a Buy at Truist
07/21/20 Lake Street
Limelight Networks price target raised to $9 from $8 at Lake Street
USX U.S. Xpress Enterprises
$9.34 /

+0.02 (+0.21%)

10/15/20 Stifel
U.S. Xpress Enterprises upgraded to Buy amid tight spot market at Stifel
10/15/20 Stifel
U.S. Xpress Enterprises upgraded to Buy from Hold at Stifel
07/29/20 BofA
U.S. Xpress Enterprises upgraded to Buy from Neutral at BofA
07/29/20 BofA
U.S. Xpress Enterprises upgraded to Buy from Neutral at BofA
EHTH eHealth
$82.01 /

+0.21 (+0.26%)

10/07/20 Deutsche Bank
eHealth growth unlikely impacted by Walmart entrance, says Deutsche Bank
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
10/06/20 Citi
Walmart entry a 'significant competitive threat' to eHealth, says Citi
09/25/20 Goldman Sachs
eHealth initiated with a Buy at Goldman Sachs
INTC Intel
$53.98 /

+0.49 (+0.92%)

10/21/20 Susquehanna
Intel checks show PC strength continues, says Susquehanna
10/20/20 Oppenheimer
Intel deal a positive for company and broader memory group, says Oppenheimer
10/20/20 Roth Capital
Roth Capital 'encouraged' by Intel's non-core divestiture efforts
10/19/20 Lynx
Intel/SK Hynix deal impact to Western, Micron 'manageable,' says Lynx
MANH Manhattan Associates
$103.40 /

+4.62 (+4.68%)

10/15/20 Truist
Manhattan Associates price target raised to $120 from $110 at Truist
07/06/20 Benchmark
Manhattan Associates price target raised to $105 from $83 at Benchmark
05/28/20 Truist
Manhattan Associates price target raised to $98 from $80 at SunTrust
05/21/20 Truist
Manhattan Associates price target raised to $80 from $70 at SunTrust
STX Seagate
$51.80 /

+0.06 (+0.12%)

10/21/20 RBC Capital
Seagate price target raised to $52 from $48 at RBC Capital
10/13/20 Morgan Stanley
Morgan Stanley upgrades IT Hardware industry view to Attractive from In-Line
09/22/20 Susquehanna
Susquehanna updates estimates for Western Digital and Seagate
09/15/20 Northland
Seagate initiated with an Outperform at Northland
VRSN VeriSign
$207.96 /

+2.22 (+1.08%)

04/24/20 Baird
VeriSign price target raised to $250 from $220 at Baird
RHI Robert Half
$56.48 /

+1.1298 (+2.04%)

07/27/20 Truist
Robert Half price target raised to $52 from $40 at SunTrust
05/21/20 Credit Suisse
Robert Half upgraded to Neutral on valuation at Credit Suisse
05/21/20 Credit Suisse
Robert Half upgraded to Neutral from Underperform at Credit Suisse
04/24/20 BMO Capital
Robert Half price target raised to $53 from $45 at BMO Capital
VRSN VeriSign
$207.96 /

+2.22 (+1.08%)

USX U.S. Xpress Enterprises
$9.34 /

+0.02 (+0.21%)

STX Seagate
$51.80 /

+0.06 (+0.12%)

SCKT Socket Mobile
$1.42 /

-0.05 (-3.40%)

SAVA Cassava Sciences
$8.84 /

-0.07 (-0.79%)

SAM Boston Beer
$918.98 /

+6.49 (+0.71%)

RHI Robert Half
$56.48 /

+1.1298 (+2.04%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MAT Mattel
$12.93 /

+0.475 (+3.81%)

MANH Manhattan Associates
$103.40 /

+4.62 (+4.68%)

LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

FFBC First Financial Bancorp
$14.53 /

+0.68 (+4.91%)

EHTH eHealth
$82.01 /

+0.21 (+0.26%)

CYBE Cyberoptics
$37.71 /

+1.31 (+3.60%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

BOOM DMC Global
$34.55 /

+1.25 (+3.75%)

  • 23
    Oct
  • 04
    Mar
  • 20
    Nov
STX Seagate
$51.80 /

+0.06 (+0.12%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

EHTH eHealth
$82.01 /

+0.21 (+0.26%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

USX U.S. Xpress Enterprises
$9.34 /

+0.02 (+0.21%)

STX Seagate
$51.80 /

+0.06 (+0.12%)

SAVA Cassava Sciences
$8.84 /

-0.07 (-0.79%)

SAM Boston Beer
$918.98 /

+6.49 (+0.71%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MAT Mattel
$12.93 /

+0.475 (+3.81%)

LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

EHTH eHealth
$82.01 /

+0.21 (+0.26%)

CYBE Cyberoptics
$37.71 /

+1.31 (+3.60%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

BOOM DMC Global
$34.55 /

+1.25 (+3.75%)

STX Seagate
$51.80 /

+0.06 (+0.12%)

SAVA Cassava Sciences
$8.84 /

-0.07 (-0.79%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MAT Mattel
$12.93 /

+0.475 (+3.81%)

LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

EHTH eHealth
$82.01 /

+0.21 (+0.26%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

Earnings
Socket Mobile reports Q3 EPS 6c vs. 1c last year » 18:44
10/22/20
10/22
18:44
10/22/20
18:44
SCKT

Socket Mobile

$1.42 /

-0.05 (-3.40%)

Reports Q3 revenue $4.1M…

Reports Q3 revenue $4.1M vs. $5.0M last year. "We were pleased to report revenue growth in Q3. We believe our Q3 results demonstrated our ability to adjust quickly to the extreme economic challenges posed by the COVID-19 pandemic and resulting uncertainties. We offset our lower revenues by proactive cost reductions, delays in non-critical discretionary spending and capital expenditures while maintaining critical longer-term projects. We also developed and implemented strategies to strengthen our balance sheet, including raising additional capital through debt financing. These actions allowed us to navigate the last two quarters well - returning to profitability in Q3, after experiencing abrupt and dramatic declines in economic and business activity in Q2," said Kevin Mills, president and CEO.

ShowHide Related Items >><<
Upgrade
ABN Amro upgraded to Buy from Neutral at Goldman Sachs » 18:42
10/22/20
10/22
18:42
10/22/20
18:42
AAVMY

ABN Amro

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Thomas Dewasmes upgraded ABN Amro to Buy from Neutral with a price target of EUR 11.40, up from EUR 11. The analyst said, while the stock's underperformance can be explained by lower profitability and other overhangs, he believes that looking through the short-term impacts ABN Amro offers material upside over the long run.

ShowHide Related Items >><<
AAVMY ABN Amro
$0.00 /

+ (+0.00%)

10/21/20 Citi
ABN Amro price target lowered to EUR 8.40 from EUR 9 at Citi
09/14/20 Societe Generale
ABN Amro upgraded to Buy from Hold at Societe Generale
09/11/20 UBS
ABN Amro price target lowered to EUR 9.50 from EUR 9.80 at UBS
08/13/20 Credit Suisse
ABN Amro price target raised to EUR 9.50 from EUR 8 at Credit Suisse
Initiation
BPER Banca reinstated with a Buy at Goldman Sachs » 18:39
10/22/20
10/22
18:39
10/22/20
18:39
BPXXY

BPER Banca

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Jean-Francois Neuez reinstated coverage of BPER Banca with a Buy rating and EUR 2.20 price target. Neuez said that the combination of sovereign spreads compression and "significant" efforts to bring down NPEs in the banking system has allowed consolidation to resume in a fragmented market. In this context, the analyst said that BPER's forthcoming absorption of 532 UBI branches will result in a large footprint expansion.

ShowHide Related Items >><<
BPXXY BPER Banca
$0.00 /

+ (+0.00%)

10/09/20 UBS
BPER Banca price target lowered to EUR 1.70 from EUR 1.96 at UBS
06/18/20 Kepler Cheuvreux
BPER Banca downgraded to Hold from Buy at Kepler Cheuvreux
06/16/20 Keefe Bruyette
BPER Banca upgraded to Outperform from Market Perform at Keefe Bruyette
06/02/20 UBS
BPER Banca upgraded to Neutral with EUR 1.90 target at UBS
Hot Stocks
Nucor CEO: We're poised and ready to return significant shareholder value » 18:28
10/22/20
10/22
18:28
10/22/20
18:28
NUE

Nucor

$49.91 /

+1.42 (+2.93%)

In an interview on…

In an interview on CNBC's Mad Money, Leon Topalian said Nucor's investments are for the long term. "We invest in the downturns to create higher highs and lower lows," he added. Non-resident construction is strong, according to Topalian, with shipments up 20% versus Q2. 70% of Nucor's inputs are recycled materials, and the company's focus on renewables will continue going forward. Topalian said Automotive will continue to be a big part of the company's business and noted Nucor is a tier 1 supplier to all major OEM's.

ShowHide Related Items >><<
NUE Nucor
$49.91 /

+1.42 (+2.93%)

NUE Nucor
$49.91 /

+1.42 (+2.93%)

10/15/20 Exane BNP Paribas
Nucor downgraded to Neutral from Outperform at Exane BNP Paribas
10/02/20 UBS
Nucor price target raised to $48 from $39 at UBS
10/01/20 Deutsche Bank
Nucor price target raised to $46 from $42 at Deutsche Bank
09/18/20 BMO Capital
Nucor price target raised to $50 from $46 at BMO Capital
NUE Nucor
$49.91 /

+1.42 (+2.93%)

NUE Nucor
$49.91 /

+1.42 (+2.93%)

NUE Nucor
$49.91 /

+1.42 (+2.93%)

Hot Stocks
SPDR Gold Shares holdings fall to 1,265.55MT from 1,269.35MT » 18:24
10/22/20
10/22
18:24
10/22/20
18:24
GLD

SPDR Gold Shares

$178.82 /

-1.84 (-1.02%)

This is the 3rd…

This is the 3rd consecutive decrease and the lowest level of holdings since September 18th.

ShowHide Related Items >><<
GLD SPDR Gold Shares
$178.82 /

-1.84 (-1.02%)

GLD SPDR Gold Shares
$178.82 /

-1.84 (-1.02%)

Periodicals
PayPal in talks to acquire Bitcoin custodian BitGo, Bloomberg reports » 18:21
10/22/20
10/22
18:21
10/22/20
18:21
PYPL

PayPal

$203.92 /

-8.94 (-4.20%)

, BTC

Bitcoin

$0.00 /

+ (+0.00%)

, BITCOIN

Bitcoin

$0.00 /

+ (+0.00%)

PayPal is looking into…

PayPal is looking into takeovers of cryptocurrency companies including Bitcoin custodian BitGo, Bloomberg's Ed Hammond and Katie Roof report, citing people familiar with the matter. The payments giant has been holding discussions with BitGo and could reach an agreement within weeks, the authors say, noting that talks could still fall apart and PayPal could decide to buy other targets. According to PitchBook, BitGo raised $58.5M in 2018 at a $170M valuation, the authors note. Reference Link

ShowHide Related Items >><<
PYPL PayPal
$203.92 /

-8.94 (-4.20%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

PYPL PayPal
$203.92 /

-8.94 (-4.20%)

10/22/20 JPMorgan
PayPal's Venmo credit card 'worth the wait,' says JPMorgan
10/22/20 Mizuho
Square selloff on 'double whammy' a buying opportunity, says Mizuho
10/21/20 Barclays
PayPal price target raised to $235 from $228 at Barclays
10/19/20 Mizuho
PayPal price target raised to $290 from $285 at Mizuho
BTC Bitcoin
$0.00 /

+ (+0.00%)

01/23/20 Morgan Stanley
PayPal acceptance gap widens against Amazon, Bitcoin, says Morgan Stanley
BITCOIN Bitcoin
$0.00 /

+ (+0.00%)

PYPL PayPal
$203.92 /

-8.94 (-4.20%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

BITCOIN Bitcoin
$0.00 /

+ (+0.00%)

PYPL PayPal
$203.92 /

-8.94 (-4.20%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

PYPL PayPal
$203.92 /

-8.94 (-4.20%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

PYPL PayPal
$203.92 /

-8.94 (-4.20%)

Hot Stocks
Pinnacle West raises quarterly dividend 6.1% to 83c per share » 18:10
10/22/20
10/22
18:10
10/22/20
18:10
PNW

Pinnacle West

$85.73 /

+2.06 (+2.46%)

The quarterly dividend is…

The quarterly dividend is payable Dec. 1 to shareholders of record at the close of business Nov. 2.

ShowHide Related Items >><<
PNW Pinnacle West
$85.73 /

+2.06 (+2.46%)

10/12/20 BofA
Pinnacle West downgraded to Underperform from Neutral at BofA
10/12/20 BofA
Pinnacle West downgraded to Underperform from Neutral at BofA
10/08/20 Mizuho
Pinnacle West initiated with a Neutral at Mizuho
10/07/20 Mizuho
Pinnacle West initiated with a Neutral at Mizuho
PNW Pinnacle West
$85.73 /

+2.06 (+2.46%)

Earnings
Investar Holding reports Q3 non-GAAP EPS 35c, consensus 29c » 18:04
10/22/20
10/22
18:04
10/22/20
18:04
ISTR

Investar Holding

$13.60 /

-0.05 (-0.37%)

Reports Q3 revenue…

Reports Q3 revenue $26.8M, consensus $20.58M. Tangible book value per common share increased to $19.27 at September 30 or 2.4% vs.$18.82 at June 30. Tangible book value per common share increased 3.8% compared to $18.56 at September 30, 2019. "I am very pleased with our results for Q3, which are a testament to both the overall strength of our organization and our customers that we serve. Since the pandemic began, we have been internally focused on our operations and financial condition. During the first nine months of the year, we have made significant changes to our deposit mix, margin, cost of funds and loan loss reserve. We have worked to develop and strengthen areas that were once weaknesses when compared to our peers. At the same time, we continue to control our expense structure and maintain a strong credit culture. Our customer relationship model of banking and multi-state strategy continue to build franchise value. We believe our geographic revenue diversification will continue to benefit the Bank in future years. (...) Our capital levels remain strong and uniquely position Investar for the future. We continue to exhibit our faith in our strategy by repurchasing over 600K shares of Investar stock since January of 2020. Our goal will remain to control the things that will create shareholder value as we come to the end of 2020."

ShowHide Related Items >><<
ISTR Investar Holding
$13.60 /

-0.05 (-0.37%)

ISTR Investar Holding
$13.60 /

-0.05 (-0.37%)

09/15/20
Fly Intel: Top analyst downgrades
09/15/20 DA Davidson
Investar Holding downgraded to Neutral from Buy at DA Davidson
06/17/20 Raymond James
Investar Holding downgraded to Market Perform from Outperform at Raymond James
06/17/20 Raymond James
Investar Holding downgraded to Market Perform from Outperform at Raymond James
ISTR Investar Holding
$13.60 /

-0.05 (-0.37%)

Hot Stocks
Medallia CEO sells 32.4K shares of common stock » 17:57
10/22/20
10/22
17:57
10/22/20
17:57
MDLA

Medallia

$31.45 /

+1.475 (+4.92%)

In a regulatory filing,…

In a regulatory filing, Medallia disclosed that its CEO Leslie Stretch sold 32.4K shares of common stock on October 20th in a total transaction size of $1.0M. The holding represents about 2% of her total owned.

ShowHide Related Items >><<
MDLA Medallia
$31.45 /

+1.475 (+4.92%)

MDLA Medallia
$31.45 /

+1.475 (+4.92%)

10/05/20 BTIG
Medallia initiated with a Buy at BTIG
09/24/20 Oppenheimer
Medallia recent selloff looks overdone, says Oppenheimer
09/04/20 Truist
Medallia price target raised to $39 from $33 at Truist
09/04/20 Roth Capital
Medallia positioned for further growth, says Roth Capital
MDLA Medallia
$31.45 /

+1.475 (+4.92%)

MDLA Medallia
$31.45 /

+1.475 (+4.92%)

Earnings
Heritage Commerce reports Q3 EPS 19c, consensus 17c » 17:55
10/22/20
10/22
17:55
10/22/20
17:55
HTBK

Heritage Commerce

$7.87 /

+0.61 (+8.40%)

"We delivered solid…

"We delivered solid earnings in the third quarter of 2020 against the backdrop of an economy affected by the Coronavirus pandemic," said Keith A. Wilton, President and Chief Executive Officer. "In the face of these challenges, we continued to work diligently to support our customers, communities and employees while prudently managing risk. Our participation in the Small Business Administration ("SBA") Paycheck Protection Program ("PPP") in the prior quarters helped us in this capacity. Loan and deposit trends remained steady and our noninterest income increased by 25% from the preceding quarter, primarily due to a $400,000 gain on sale of SBA loans and a $310,000 gain realized on a warrant that we exercised. As anticipated, our net interest margin contracted during the quarter following the 150 basis point rate reduction by the Federal Reserve Bank earlier in the year and the low interest rates on recently funded SBA PPP loans."

ShowHide Related Items >><<
HTBK Heritage Commerce
$7.87 /

+0.61 (+8.40%)

12/19/19 Sandler O'Neill
Heritage Commerce reinstated with a Buy at Sandler O'Neill
HTBK Heritage Commerce
$7.87 /

+0.61 (+8.40%)

Hot Stocks
VeriSign CEO sells 6K shares of common stock » 17:54
10/22/20
10/22
17:54
10/22/20
17:54
VRSN

VeriSign

$207.96 /

+2.22 (+1.08%)

In a regulatory filing,…

In a regulatory filing, VeriSign disclosed that its CEO James Bidzos sold 6K shares of common stock on October 21st in a total transaction size of $1.23M. The holding represents about 1% of his total owned.

ShowHide Related Items >><<
VRSN VeriSign
$207.96 /

+2.22 (+1.08%)

VRSN VeriSign
$207.96 /

+2.22 (+1.08%)

04/24/20 Baird
VeriSign price target raised to $250 from $220 at Baird
VRSN VeriSign
$207.96 /

+2.22 (+1.08%)

General news
Dallas Federal Reserve Bank President Robert Kaplan Speech to be released at 18:00  17:45
10/22/20
10/22
17:45
10/22/20
17:45
 
Hot Stocks
Leidos awarded $149.24M Navy contract » 17:31
10/22/20
10/22
17:31
10/22/20
17:31
LDOS

Leidos

$85.79 /

+1.25 (+1.48%)

Leidos was awarded a…

Leidos was awarded a $149.24M indefinite-delivery/indefinite-quantity contract containing cost-plus-fixed-fee, cost reimbursement and firm-fixed-price provisions. This contract provides services and supplies for the operation of the Naval Array Technical Support Center facility. Work is expected to be completed in November 2025. Service Cost Center funding in the amount of $13.84M will be obligated on the first task order and will not expire at the end of the current fiscal year. This contract was competitively procured using full and open competition via the Federal Business Opportunities website with four offers received. The Naval Undersea Warfare Center Division is the contracting activity.

ShowHide Related Items >><<
LDOS Leidos
$85.79 /

+1.25 (+1.48%)

LDOS Leidos
$85.79 /

+1.25 (+1.48%)

09/23/20 Barclays
Barclays upgrades Leidos to Overweight, sees above peer growth in 2021
09/23/20 Barclays
Leidos upgraded to Overweight from Equal Weight at Barclays
09/22/20 JPMorgan
Leidos upgraded to Overweight on bottomed estimates at JPMorgan
09/22/20 JPMorgan
Leidos upgraded to Overweight from Neutral at JPMorgan
LDOS Leidos
$85.79 /

+1.25 (+1.48%)

LDOS Leidos
$85.79 /

+1.25 (+1.48%)

LDOS Leidos
$85.79 /

+1.25 (+1.48%)

Periodicals
USPS delivers over 100M blank or completed ballots so far, Reuters says » 17:31
10/22/20
10/22
17:31
10/22/20
17:31
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$344.63 /

+1.95 (+0.57%)

The U.S. Postal Service…

The U.S. Postal Service said it has delivered over 100M blank or completed ballots since early last month for the upcoming U.S. presidential election, Reuters' David Shepardson reports. Officials during a media briefing said that the USPS was well positioned to deliver ballots in a timely manner and outlined several steps, Shepardson says, noting that 523M pieces of election mail have entered the USPS network, a 162% increase over the 2016 presidential election. "Election mail will not be delayed," said Kristin Seaver, USPS chief retail and delivery officer. Reference Link

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPY SPDR S&P 500 ETF Trust
$344.63 /

+1.95 (+0.57%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$344.63 /

+1.95 (+0.57%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$344.63 /

+1.95 (+0.57%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.